The synthetic bryostatin analog Merle 23 dissects distinct mechanisms of bryostatin activity in the LNCaP human prostate cancer cell line
FƔjlok
DƔtum
2011
FolyĆ³irat cĆme
FolyĆ³irat ISSN
Kƶtet cĆme (Ć©vfolyam szĆ”ma)
KiadĆ³
Absztrakt
LeĆrĆ”s
Kulcsszavak
ForrƔs
Biochemical Pharmacology. -81 : 11 (2011), p. 1296-1308. -Biochem. Pharmacol. - 0006-2952